Heska develops new allergy product
In order to develop the product, Heska leveraged intellectual property developed by Dr. Mary Morris & Associates, located in La Crosse, Wis. The advance will support Heska's production of allergy treatments delivered under the tongue of an animal.
It is estimated that between 10 and 15 percent of dogs are affected by allergies, according to Michael McGinley, president and CEO of Heska.
"This expanded commitment to our allergy franchise is consistent with our strategy of offering valuable products in important areas of veterinary medicine," McGinley said. Because the new treatment can be administered under an animal's tongue, it improves the likelihood of pet owner compliance, he said.
More breaking news...
CU hosting pair of entrepreneurial challenges
Fort Collins-based New Belgium is building a 133,000-square-foot brewery
Loveland resets date for fracking moratorium election
The CUCleantech New Venture Challenge - a regional semifinal for the national competition in
The Loveland City Council this week agreed to hold the election June 24, the same day